Clinical trials
Completed Phase 3 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,202 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 5 |
| 2002 | 11 |
| 2003 | 23 |
| 2004 | 35 |
| 2005 | 29 |
| 2006 | 77 |
| 2007 | 75 |
| 2008 | 90 |
| 2009 | 116 |
| 2010 | 113 |
| 2011 | 156 |
| 2012 | 150 |
| 2013 | 127 |
| 2014 | 133 |
| 2015 | 125 |
| 2016 | 138 |
| 2017 | 142 |
| 2018 | 116 |
| 2019 | 121 |
| 2020 | 104 |
| 2021 | 100 |
| 2022 | 76 |
| 2023 | 61 |
| 2024 | 29 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,202 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 118 |
| Novartis Pharmaceuticals | 113 |
| Eli Lilly and Company | 110 |
| AstraZeneca | 98 |
| Pfizer | 92 |
| Novo Nordisk A/S | 91 |
| Boehringer Ingelheim | 79 |
| Takeda | 79 |
| Bayer | 70 |
| Sanofi | 70 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 160 |
| Diabetes Mellitus | 74 |
| Asthma | 55 |
| Arthritis, Rheumatoid | 53 |
| Breast Neoplasms | 48 |
| Carcinoma, Non-Small-Cell Lung | 47 |
| Pulmonary Disease, Chronic Obstructive | 45 |
| Stomach Neoplasms | 39 |
| Dermatitis, Atopic | 36 |
| Psoriasis | 36 |
Trials
Showing 1 to 25 of 2,202. Each trial links to its page on Pharma Observatory.
2,102 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.